GB0003898D0 - Assay - Google Patents

Assay

Info

Publication number
GB0003898D0
GB0003898D0 GBGB0003898.4A GB0003898A GB0003898D0 GB 0003898 D0 GB0003898 D0 GB 0003898D0 GB 0003898 A GB0003898 A GB 0003898A GB 0003898 D0 GB0003898 D0 GB 0003898D0
Authority
GB
United Kingdom
Prior art keywords
assay
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0003898.4A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Priority to GBGB0003898.4A priority Critical patent/GB0003898D0/en
Publication of GB0003898D0 publication Critical patent/GB0003898D0/en
Priority to AU33895/01A priority patent/AU3389501A/en
Priority to PCT/GB2001/000693 priority patent/WO2001061360A2/en
Ceased legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/566—Immunoassay; Biospecific binding assay; Materials therefor using specific carrier or receptor proteins as ligand binding reagents where possible specific carrier or receptor proteins are classified with their target compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
    • G01N2333/72—Assays involving receptors, cell surface antigens or cell surface determinants for hormones
    • G01N2333/726—G protein coupled receptor, e.g. TSHR-thyrotropin-receptor, LH/hCG receptor, FSH
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
GBGB0003898.4A 2000-02-18 2000-02-18 Assay Ceased GB0003898D0 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
GBGB0003898.4A GB0003898D0 (en) 2000-02-18 2000-02-18 Assay
AU33895/01A AU3389501A (en) 2000-02-18 2001-02-19 Assay
PCT/GB2001/000693 WO2001061360A2 (en) 2000-02-18 2001-02-19 Identification of modulators of gpr31 activity

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0003898.4A GB0003898D0 (en) 2000-02-18 2000-02-18 Assay

Publications (1)

Publication Number Publication Date
GB0003898D0 true GB0003898D0 (en) 2000-04-05

Family

ID=9885980

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0003898.4A Ceased GB0003898D0 (en) 2000-02-18 2000-02-18 Assay

Country Status (3)

Country Link
AU (1) AU3389501A (en)
GB (1) GB0003898D0 (en)
WO (1) WO2001061360A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040254224A1 (en) * 2001-04-11 2004-12-16 Foord Steven Michael Medicaments
WO2005059561A2 (en) * 2003-12-12 2005-06-30 Bayer Healthcare Ag Diagnostics and therapeutics for diseases associated with g protein-coupled receptor 31 (gpr31)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6555339B1 (en) * 1997-04-14 2003-04-29 Arena Pharmaceuticals, Inc. Non-endogenous, constitutively activated human protein-coupled receptors

Also Published As

Publication number Publication date
WO2001061360A2 (en) 2001-08-23
WO2001061360A3 (en) 2002-03-28
AU3389501A (en) 2001-08-27

Similar Documents

Publication Publication Date Title
EP1442299A4 (en) Assay
GB0115777D0 (en) Assay
GB0003069D0 (en) Improved assay
GB0012860D0 (en) Assay
GB0008784D0 (en) Assay
GB0003902D0 (en) Assay
GB0005894D0 (en) Assay
GB0005895D0 (en) Novel assay
GB0014838D0 (en) An assay
GB0010960D0 (en) Assay
GB0101313D0 (en) Assay
GB0001703D0 (en) Assay
GB0025804D0 (en) Assay
GB0121440D0 (en) Assay
GB0003898D0 (en) Assay
GB0019242D0 (en) Assay
GB0023239D0 (en) Assay
GB0013561D0 (en) Assay
GB0020083D0 (en) Assay 14
GB0127132D0 (en) Assay
GB0024184D0 (en) An assay
GB0029001D0 (en) Assay
GB0100782D0 (en) Assay
GB0101312D0 (en) Assay
GB0006004D0 (en) Assay

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)